Impact of Xpert MTB/RIF and decentralized care on linkage to care and drug-resistant tuberculosis treatment outcomes in Johannesburg, South Africa

BACKGROUND: In 2011, South Africa improved its ability to test for rifampicin-resistant TB (RR-TB) by introducing GeneXpert MTB/RIF. At the same time, the South African National TB program adopted a policy decentralized, outpatient treatment for drug resistant (DR-) TB. We aim to analyze the impact...

Descripción completa

Detalles Bibliográficos
Autores principales: Evans, Denise, Sineke, Tembeka, Schnippel, Kathryn, Berhanu, Rebecca, Govathson, Caroline, Black, Andrew, Long, Lawrence, Rosen, Sydney
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296148/
https://www.ncbi.nlm.nih.gov/pubmed/30558670
http://dx.doi.org/10.1186/s12913-018-3762-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296148/
https://www.ncbi.nlm.nih.gov/pubmed/30558670
http://dx.doi.org/10.1186/s12913-018-3762-x

Ejemplares similares